Prof. Carlos Alberto Mateus Afonso, carlosafonso@ff.ulisboa.pt
FFUL (http://www.ff.ulisboa.pt) is a highly regarded research-oriented institution in Pharmaceutical Sciences. Ranking first among the Schools of Pharmacy in Portugal, it provides programs of excellence in scientific and professional areas. FFULisboa has around 1600 students (1200 in Integrated Master of Pharmaceutical Sciences, 250 in other 2nd Cycles and 120 PhD students). FFULisboa hosts the Research Institute for Medicines (iMed.ULisboa), a multidisciplinary R&D Unit in Life and Health Sciences supported by FCT (http://www.imed.ulisboa.pt). iMed.ULisboa mission is to develop innovative medicines and benefit human health through top-class multidisciplinary research. Capabilities are built around a network of 15 research groups, spanning the drug discovery and development spectrum, with an emphasis on innovative, multidisciplinary, and collaborative research. iMed.ULisboa hosts 115 PhD researchers and 85 PhD students, and is heavily committed to enabling scientists and training students. Leading the PhD Programme in Medicines and Pharmaceutical Innovation (http://www.ff.ul.pt/phd3duul/) and partnering in several networks and consortia, iMed.ULisboa promotes national productivity and competitiveness in drug discovery and development, and facilitates international academic and industrial partnerships. FF/ULisboa provides administrative support, office and laboratory space, access to infrastructures, human resources and technical support. FFULisboa is member of several networks and consortia that promote initiatives to increase national competitiveness, innovation and technology in health care.
Available facilities include cell analysis (cell culture; cell lines bank; cell-based, high throughput biomolecular screening; electrophysiology; biosafety level 3; flow cytometry; gene expression, siRNA, shRNA, viral production; bioimaging; bioinformatics); certified animal facilities; protein production and analysis (computer optimized fermentator, high-throughput robotized antibody screening); medicinal chemistry (Linux-based high performance computer cluster with state-of-the-art software for molecular modelling; MS ion-trap and triple quadrupole MS; 300, 400 MHz NMR instruments; FT-IR; elemental analysis; medium throughput separation of compounds; parallel and solid-phase chemistry; reactors for microwave-assisted and photochemical chemistries); and nanosystem formulation and characterization (Malvern Particle analyzer Nano-S Size; Malvern Zeta potential analyzer). In addition, the laboratory of Afonso is equipped with the required facilities for organic chemistry namely GC-MS, GC, HPLC, LC-MS, UV, flow equipment, hydrogenator, ozone generator, rotaevaporators and other small equipment’s and for toxicity evaluation such as CO2 cell culture incubator and microscope.
Prof. Jan Deska, jan.deska@helsinki.fi
Aalto University (est. 2010, formerly known as Helsinki University of Technology) is rapidly gaining reputation among the young universities, with a highly multidisciplinary approach to all areas of research and education. The Department of Chemistry, as part of the Aalto School of Chemical Technology, hosts among other things Finland's national Bioeconomy Infra Platform providing unlimited access and technical support for a wide range of analytical facilities and services including state-of-the-art NMR and EPR, and a broad selection of chromatographic tools (LC-MS, GC-MS, GC-FID, HPLC, UPLC). The laboratory of Bioorganic Chemistry, headed by Prof. Deska, is equipped with all necessary facilities for organic synthesis and the handling and evaluation of bio-based reaction systems (enzymatic as well as cellular). As part of the Aalto Biotech Team, the Deska group can furthermore provide molecular biology and biotechnology tools and address enzyme synthesis and purification.
The National Institute of Neurology has been the first Institute specialized in Neurology and Neuropathology in Africa created on 1974. In 2012, its name has been dedicated to its founder Mongi Ben Hmida. The Institute contains research laboratory and platform for neurology disease and another fundamental sciences. The National Institute Mongi Ben Hmida of Neurology is global reference center for Neurosciences. The National Institute Mongi Ben Hmida of Neurology is classified as most active health institution in research production in Tunisia, in 2012, it have received the price form Arab League for the best research institute in M.E.N.A.(Middle East and North Africa) region. National Institute of Neurology contains two research laboratories which used several equipment’s for biochemical and molecular analysis: Spectrophotometer Agilent-Vary, Electrophoresis automate, Cobas biochemical assays automate, etc. The institute belongs to the university hospital-centre La Rabta which contains GC-MS, GC-MS/MS and LC-MS. Moreover, the institute could beneficiate by the platform of Faculty of Medicine containing also several equipment’s such fluorescent-luminescent micro-plate lecturer (Victor X), you can visit the website for further information about equipment’s available ( http://www.Plateforme-recherche-fmt.tn).
Lieutenant Colonel (Lt Col) Vânia Tira-Picos, tira-picos.vccm@mail.exercito.pt
The Chemical Defense Laboratory of the Army (LabDefQE) is integrated in the Military Laboratorial Unit of Biological and Chemical Defense (UMLDBQ) of the Portuguese Army. This laboratory has the facilities and the proper equipment to safely analyse toxic chemicals, namely GC, GC-MS e LC-MS attached to specific detectors, such as Mass Spetrometers of Ion Trap and Quadropole; Atomic Emission Detector (AED); and a LC-HRMS (Liquid chromatography–high resolution mass spectrometry). In addition, LabDefQE also have a negative air pressure cleanroom integrated with a class II type B2 biosafety cabinet with total-exhaust.
Optimal works in the development of hardware and software systems able to assist the first responders, national planning authorities and industry to act in a coordinated and complementary way.
The company evolved to provide solutions for responding to chemical, biological and radiological incidents and has experience on leveraging early TRL developments into marketable products and services for CBRNe solutions.